VISTAGEN THERAPEUTICS, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- VISTAGEN THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2024-09-30 was $20.00K, a 99.94% decline year-over-year.
- VISTAGEN THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2023-09-30 was $34.80M.
- VISTAGEN THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2023-06-30 was $1.10M.
- VISTAGEN THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2021-12-31 was $41.30K, a 99.96% decline year-over-year.
- VISTAGEN THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2026 was $30.59M, a 919.53% increase from fiscal 2025.
- VISTAGEN THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2025 was $3.00M, a 91.64% decline from fiscal 2024.
- VISTAGEN THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2024 was $35.90M.
- VISTAGEN THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2022 was $4.30M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-03-31 | $30.59M 10-K · filed 2026-06-15 | |
| 2025-03-31 | $3.00M 10-K · filed 2025-06-17 | |
| 2024-09-30 | $20.00K 10-Q · filed 2024-11-07 | |
| 2024-03-31 | $35.90M 10-K · filed 2024-06-11 | |
| 2023-09-30 | $34.80M 10-Q · filed 2025-02-13 | |
| 2023-06-30 | $1.10M 10-Q · filed 2025-02-13 | |
| 2022-03-31 | $4.30M 10-K · filed 2023-06-28 | |
| 2021-12-31 | $41.30K 10-Q · filed 2023-02-07 | |
| 2021-09-30 | $4.26M 10-Q · filed 2023-02-07 | |
| 2020-12-31 | $93.65M 10-Q · filed 2022-02-10 | |
| 2020-09-30 | $49.30K 10-Q · filed 2022-02-10 | |
| 2020-06-30 | $50.00K 10-Q · filed 2021-02-11 | |
| 2019-12-31 | $650.00K 10-Q · filed 2021-02-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |